Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Emory University
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute